Verma Abhimanyu 4
4 · SOPHiA GENETICS SA · Filed Jul 7, 2026
Research Summary
AI-generated summary of this filing
SOPHiA GENETICS (SOPH) CTO Abhimanyu Verma Sells 5,285 Shares
What Happened
Abhimanyu Verma, Chief Technology Officer of SOPHiA GENETICS SA (SOPH), sold 5,285 shares on July 6, 2026 in an open-market transaction. The reported weighted-average sale price was $5.10 per share for proceeds of $26,957 (sales executed at prices ranging $4.97–$5.41). This was a sale to satisfy tax withholding and not a new equity purchase.
Key Details
- Transaction date: July 6, 2026 (Form filed July 7, 2026).
- Transaction type/code: Sale (S).
- Shares sold: 5,285; weighted-average price: $5.10; total reported proceeds: $26,957.
- Price range: shares were sold in multiple trades at $4.97 to $5.41 (footnote states the reporter can provide the per-price breakdown on request).
- Reason/footnotes: Sold to satisfy tax withholding on RSU vestings on July 2 and July 3, 2026; transactions were executed under a pre-established Rule 10b5-1(c) trading plan and were non-discretionary (F1). (F2 explains the weighted-average price and price range.)
- Shares owned after transaction: Not specified in the information provided in your summary.
- Timeliness: Filed the day after the transaction (no late filing indicated in the provided details).
Context
These sales were routine tax-withholding dispositions tied to restricted stock unit vesting and executed under a 10b5-1 plan, which typically reflect pre-planned, non-discretionary activity rather than an ad hoc view on the company’s prospects. For further detail (exact number of shares sold at each price), the reporting person offers to provide the breakdown to the issuer, any shareholder, or the SEC staff upon written request.
Insider Transaction Report
- Sale
Ordinary Shares
[F1][F2]2026-07-06$5.10/sh−5,285$26,957→ 192,171 total
Footnotes (2)
- [F1]Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on July 2 and July 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.97 to $5.41, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.